Funding Opportunities

BHF CRC Research Development Fund

Open for Funding

The aim of this fund is to support the development of ideas or gather pilot data in preparation for a larger clinical study program. Examples might include:

  • Assessment of clinical research priorities (including service user reviews)
  • Systematic reviews
  • Grant targeting and preparation
  • Collecting meaningful pilot data
  • Study development – collaborative work to develop a study protocol, optimise a study design and analysis plan

Funding is available up to £10,000. Please note that this fund is not intended to fund the performance of independent clinical research and should be used to aid the development of future larger scale clinical research activity.

Applications must be accompanied by a letter of support from a lead research group (RG) of an integrated BHF CRC society as listed on the website (BHRS are one of them) and an application form. Other RGs may also offer support, but one RG must act as the main supporter.

An RG can choose to support up to 2 applications; if an RG acts as the main supporter for more than one application, that RG must prioritise the applications and indicate this on their letter of support.

Round 3 is open from the 14th March 2022 with a closing date at 23.59 hours on the 15th May 2022. The total amount of funding available for round two is £40,000. Successful applicants will be notified by the 15th of July 2022

PLEASE EMAIL APPLICATIONS to Professor Pier Lambiase (BHRS Committee Research Lead) by 1st of MAY so they can be adjudicated & ranked and the top 3 applications will be put forward by the BHRS Research Committee.


For your information these were the successful applications from the second round:

Second Round of BHF CRC Research Development Funds Awarded

The Research Development Fund was launched in February 2021 to fund projects that contributed to the development of clinical research, in turn leading to further research activity. The BHF CRC are pleased to announce that 5 applications were successful from our second funding call, covering a variety of clinical cardiovascular specialities and themes. The successful projects are as follows:

  • Pilot implementation of an AI algorithm in routinely-collected UK primary care electronic health records (EHRs). This algorithm can reduce the number of screenings needed for new atrial fibrillation cases in people ≥75 years of age to 11 whilst the national AF screening programme may prevent 10% of strokes and save the NHS £200 million per year.
  • Preparatory work including some initial data collection and feedback on trial design ahead of a funding application for a registry-based Randomised Controlled Trial (R-RCT) of furosemide versus bumetanide for the treatment of patients recently hospitalised with decompensated heart failure (FAB-HF).
  • Development of pragmatic methodology and intervention components ahead of a proposed multi-centre randomised controlled trial that compares patient centred ambulatory care supported by remote monitoring to usual outpatient clinic care for those with ACHD, by repurposing existing resources.
  • A Cochrane Network Meta-Analysis of transcatheter versus surgical treatments of secondary MR (sMR). The project will compare evidence from randomised controlled trials to better identify sMR patient subgroups who would benefit most from the respective interventions.
  • Establishing a database of cardiovascular patients using HES and linked mortality data. This database will be used to model trials in silico which in turn be used to inform funding applications for clinical trials that address priority research questions in cardiac surgery.